June 3, 2010 – A joint research agreement will explore the targeted delivery of experimental therapeutics based on ribonucleic acid (RNA) interference (RNAi). Philips Healthcare and RXi Pharmaceuticals Corp. say imaging compounds based on RNAi represent a promising new class of drugs for the targeted treatment of a number of diseases including cancer and cardiovascular disease.

June 2, 2010 – Covidien announced yesterday it is purchasing ev3 Inc. for $2.6 billion to expand its percutaneous vascular portfolio. The company hopes to become a leading endovascular player in both the peripheral vascular and neurovascular markets.

June 2, 2010 – Key research on new diagnostic uses for cardiac ultrasound will be presented at the American Society of Echocardiography (ASE) 21st Annual Scientific Sessions June 12-15, in San Diego. Leading experts in cardiology will present and discuss the latest clinical and research developments in adult and pediatric echocardiography. Among the key presentations are:

June 1, 2010 – A teleproctoring technology uses robotic technology to teach physicians about new procedures without the additional expense of travel.

May 27, 2010 – Positive results from CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial) will be used to expand the U.S. Food and Drug Administration (FDA) indication for carotid stents.

May 27, 2010 – One-year data presented this week at EuroPCR in Paris confirms sustained clinical outcomes with Cook Medical's drug-eluting peripheral stent, Zilver PTX.

May 26, 2010 – The first angioplasty balloon catheter to integrate intravascular ultrasound (IVUS) imaging has gained CE-mark clearance in Europe. Volcano Corp. also announced today it completed its first clinical cases with the Vibe RX catheter in New Zealand.